| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |